Mao Wenhui, Watkins David, Sabin Miriam L, Huang Katy, Langlois Etienne, Ogundeji Yewande, Fogstad Helga, Schäferhoff Marco, Yamey Gavin, Ogbuoji Osondu
Center for Policy Impact in Global Health, Duke Global Health Institute, Durham, NC, USA.
Seattle, WA, USA.
Lancet Glob Health. 2023 Apr;11(4):e597-e605. doi: 10.1016/S2214-109X(23)00056-6.
Maternal and newborn mortality rates in Nigeria are among the highest globally, and large socioeconomic inequalities exist in access to maternal, newborn, and child health (MNCH) services in the country. Inequalities also exist in catastrophic health expenditure among households in Nigeria. We aimed to estimate the health and financial risk protection benefits across different wealth groups in Nigeria if a policy of public financing of MNCH interventions were to be introduced.
We did an extended cost-effectiveness analysis to estimate the health and financial risk protection benefits, across different household wealth quintiles, of a public-financing policy that assumes zero out-of-pocket costs to patients at the point of care for 18 essential MNCH services. We projected health outcomes (deaths in children aged <5 years [under-5 deaths] and maternal deaths) and private expenditure averted using the Lives Saved Tool with data extracted from national surveys. We modelled three scenarios: 1) coverage expansion at a rate equal to the trend observed between 2013 and 2018 (status quo); 2) annual coverage expansion by 5% compared with the status quo (uniform scale-up scenario); and 3) annual coverage expansion by 10%, 8%, 6%, 4%, and 2% compared with the status quo from the poorest to the wealthiest quintiles, respectively (pro-poor scale-up scenario).
Our analysis shows that, if an additional 5% increase in coverage was provided for all wealth quintiles between 2019 and 2030, this uniform scale-up policy would prevent more than 0·11 million maternal deaths and 1·05 million under-5 deaths, avert US$1·8 billion in private expenditure, and avert 3266 cases of catastrophic health expenditure. The incremental cost effectiveness ratio would be $44 per life-year gained, which is highly cost-effective when compared with the gross domestic product per capita of Nigeria for 2018 ($2028). The policy would prevent a higher number of under-5 deaths and catastrophic health expenditure cases in poorer quintiles, but would prevent more maternal deaths and private expenditure in wealthier quintiles. If poorer populations experienced a greater increase in service coverage (ie, the pro-poor scale-up scenario), more maternal and under-5 deaths would be prevented in the poorer quintiles and more private expenditure would be averted than would be under previous scenarios.
Public financing of essential MNCH interventions in Nigeria would provide substantial health and financial risk protection benefits to Nigerian households. These benefits would accrue preferentially to the poorest quintiles and would contribute towards reduction of health and socioeconomic inequalities in Nigeria. The distribution would be more pro-poor if public financing of MNCH interventions could target poor households.
WHO Partnership for Maternal, Newborn, and Child Health.
尼日利亚的孕产妇和新生儿死亡率位居全球最高之列,该国在获得孕产妇、新生儿和儿童健康(MNCH)服务方面存在巨大的社会经济不平等。尼日利亚家庭在灾难性医疗支出方面也存在不平等现象。我们旨在估计,如果引入一项为MNCH干预措施提供公共资金的政策,尼日利亚不同财富群体在健康和财务风险保护方面的收益。
我们进行了一项扩展的成本效益分析,以估计一项公共融资政策在不同家庭财富五分位数中的健康和财务风险保护收益,该政策假定患者在接受18项基本MNCH服务时无需自掏腰包。我们使用从国家调查中提取的数据,通过“挽救生命工具”预测健康结果(5岁以下儿童死亡[五岁以下儿童死亡]和孕产妇死亡)以及避免的私人支出。我们模拟了三种情景:1)以2013年至2018年观察到的趋势相同的速度扩大覆盖范围(现状);2)与现状相比,每年覆盖范围扩大5%(统一扩大情景);3)与现状相比,从最贫困到最富裕的五分位数分别每年覆盖范围扩大10%、8%、6%、4%和2%(扶贫扩大情景)。
我们的分析表明,如果在2019年至2030年期间为所有财富五分位数额外增加5%的覆盖范围,这项统一扩大政策将预防超过11万例孕产妇死亡和105万例五岁以下儿童死亡,避免18亿美元的私人支出,并避免3266例灾难性医疗支出。增量成本效益比将为每获得一个生命年44美元,与2018年尼日利亚的人均国内生产总值(2028美元)相比,这具有很高的成本效益。该政策将在较贫困的五分位数中预防更多的五岁以下儿童死亡和灾难性医疗支出病例,但在较富裕的五分位数中预防更多的孕产妇死亡和私人支出。如果较贫困人群的服务覆盖范围有更大的增加(即扶贫扩大情景),较贫困的五分位数中将预防更多的孕产妇和五岁以下儿童死亡,并且与之前的情景相比,将避免更多的私人支出。
尼日利亚为基本MNCH干预措施提供公共资金将为尼日利亚家庭带来巨大的健康和财务风险保护收益。这些收益将优先惠及最贫困的五分位数人群,并有助于减少尼日利亚的健康和社会经济不平等。如果MNCH干预措施的公共资金能够针对贫困家庭,分配将更加有利于穷人。
世界卫生组织孕产妇、新生儿和儿童健康伙伴关系。